The AKT1 gene is associated with attention and brain morphology in schizophrenia

References

• Alexander GE, DeLong MR, Strick PL. 1986. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357–381.
   PubMed Web of Science ®Google Scholar
• Ashburner J, and Friston KJ. 2000. Voxel-based morphometry – the methods. Neuroimage 11:805–821.
   PubMed Web of Science ®Google Scholar
• Bajestan SN, Sabouri AH, Nakamura M, Takashima H, Keikhaee MR, Behdani F, . 2006. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population. Am J Med Genet B Neuropsychiatr Genet 141B:383–386.
   PubMedGoogle Scholar
• Balu DT, Carlson GC, Talbot K, Kazi H, Hill-Smith TE, Easton RM, . 2011. Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function. Hippocampus.
   Web of Science ®Google Scholar
• Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, . 2004. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 101: 5099–5104.
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. 2005. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122:261–273.
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Gainetdinov RR, Caron MG. 2007a. The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci 28:166–172.
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Tirotta E, Sotnikova TD, Masri B, Salahpour A, Gainetdinov RR, . 2007b. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci 27: 881–885.
   PubMed Web of Science ®Google Scholar
• Betcheva ET, Mushiroda T, Takahashi A, Kubo M, Karachanak SK, Zaharieva IT, . 2009. Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet 54:98–107.
   PubMed Web of Science ®Google Scholar
• Blasi G, Napolitano F, Ursini G, Taurisano P, Romano R, Caforio G, . 2011. DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia. Proc Natl Acad Sci USA 108:1158–1163.
   PubMed Web of Science ®Google Scholar
• Cardno AG, and Gottesman, II. 2000. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 97:12–17.
   PubMed Web of Science ®Google Scholar
• Chan RC, Di X, McAlonan GM, Gong QY. 2011. Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: An activation likelihood estimation meta-analysis of illness progression. Schizophr Bull 37:177–188.
   PubMed Web of Science ®Google Scholar
• Chen WJ, Faraone SV. 2000. Sustained attention deficits as markers of genetic susceptibility to schizophrenia. Am J Med Genet 97:52–57.
   PubMed Web of Science ®Google Scholar
• Cornblatt BA, Keilp JG. 1994. Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull 20: 31–46.
   PubMed Web of Science ®Google Scholar
• Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L. 1988. The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res 26:223–238.
   PubMed Web of Science ®Google Scholar
• Cornblatt BA, Lenzenweger MF, Erlenmeyer-Kimling L. 1989. The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients. Psychiatry Res 29:65–85.
   PubMed Web of Science ®Google Scholar
• Ellison-Wright I, Bullmore E. 2010. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res 117:1–12.
   PubMed Web of Science ®Google Scholar
• Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. 2004. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 36:131–137.
   PubMed Web of Science ®Google Scholar
• Freyberg Z, Ferrando SJ, Javitch JA. 2010. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am J Psychiatry 167:388–396.
   PubMed Web of Science ®Google Scholar
• Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. 2001. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14: 21–36.
   PubMed Web of Science ®Google Scholar
• Green MF. 2006. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 67(Suppl 9):3–8; discussion 36–42.
   PubMed Web of Science ®Google Scholar
• Grimes CA, Jope RS. 2001. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65:391–426.
   PubMed Web of Science ®Google Scholar
• Gupta A, Schulze TG, Nagarajan V, Akula N, Corona W, Jiang XY, . 2011. Interaction networks of lithium and valproate molec ular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling. Pharmacogenom J., in press.
   Web of Science ®Google Scholar
• Harris SL, Gil G, Robins H, Hu W, Hirshfield K, Bond E, . 2005. Detection of functional single-nucleotide polymorphisms that affect apoptosis. Proc Natl Acad Sci USA 102: 16297–16302.
   PubMed Web of Science ®Google Scholar
• Hashimoto R, Numakawa T, Ohnishi T, Kumamaru E, Yagasaki Y, Ishimoto T, . 2006. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet 15:3024–3033.
   PubMed Web of Science ®Google Scholar
• Hashimoto R, Hashimoto H, Shintani N, Chiba S, Hattori S, Okada T, . 2007. Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol Psychiatry 12:1026–1032.
   PubMed Web of Science ®Google Scholar
• Horwood JM, Dufour F, Laroche S, Davis S. 2006. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Eur J Neurosci 23:3375–3384.
   PubMed Web of Science ®Google Scholar
• Ide M, Ohnishi T, Murayama M, Matsumoto I, Yamada K, Iwayama Y, . 2006. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia. J Neurochem 99:277–287.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, . 2004. Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol Psychiatry 56:698–700.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Yamanouchi Y, Kinoshita Y, Kitajima T, Yoshimura R, Hashimoto S, . 2008. Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia. Pharmacogenomics 9:1437–1443.
   PubMed Web of Science ®Google Scholar
• Kang UG, Seo MS, Roh MS, Kim Y, Yoon SC, Kim YS. 2004. The effects of clozapine on the GSK-3-mediated signaling pathway. FEBS Lett 560:115–119.
   PubMed Web of Science ®Google Scholar
• Karege F, Perroud N, Schurhoff F, Meary A, Marillier G, Burkhardt S, . 2010. Association of AKT1 gene variants and protein expression in both schizophrenia and bipolar disorder. Genes Brain Behav 9:503–511.
   PubMed Web of Science ®Google Scholar
• Lai WS, Xu B, Westphal KG, Paterlini M, Olivier B, Pavlidis P, . 2006. Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc Natl Acad Sci USA 103:16906–16911.
   PubMed Web of Science ®Google Scholar
• Lee KY, Joo EJ, Jeong SH, Kang UG, Roh MS, Kim SH, . 2010. No association between AKT1 polymorphism and schizophrenia: a case-control study in a Korean population and a meta-analysis. Neurosci Res 66:238–245.
   PubMed Web of Science ®Google Scholar
• Lin CH, Yeh SH, Lu KT, Leu TH, Chang WC, Gean PW. 2001. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 31:841–851.
   PubMed Web of Science ®Google Scholar
• Liu YL, Fann CS, Liu CM, Wu JY, Hung SI, Chan HY, . 2006. Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population. Psychiatr Genet 16:39–41.
   PubMed Web of Science ®Google Scholar
• Mathur A, Law MH, Megson IL, Shaw DJ, Wei J. 2010. Genetic association of the AKT1 gene with schizophrenia in a British population. Psychiatr Genet 20:118–122.
   PubMed Web of Science ®Google Scholar
• Meyer-Lindenberg A, Weinberger DR. 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7:818–827.
   PubMed Web of Science ®Google Scholar
• Mizuno M, Yamada K, Takei N, Tran MH, He J, Nakajima A, . 2003. Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation. Mol Psychiatry 8:217–224.
   PubMed Web of Science ®Google Scholar
• Norton N, Williams HJ, Dwyer S, Carroll L, Peirce T, Moskvina V, . 2007. Association analysis of AKT1 and schizophrenia in a UK case control sample. Schizophr Res 93:58–65.
   PubMed Web of Science ®Google Scholar
• Ohtsuki T, Inada T, Arinami T. 2004. Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case-control population. Mol Psychiatry 9:981–983.
   PubMed Web of Science ®Google Scholar
• Pantelis C, Barnes TR, Nelson HE, Tanner S, Weatherley L, Owen AM, . 1997. Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 120(Pt 10): 1823–1843.
   PubMedGoogle Scholar
• Pietilainen OP, Paunio T, Loukola A, Tuulio-Henriksson A, Kieseppa T, Thompson P, . 2009. Association of AKT1 with verbal learning, verbal memory, and regional cortical gray matter density in twins. Am J Med Genet B Neuropsychiatr Genet 150B:683–692.
   PubMed Web of Science ®Google Scholar
• Pinheiro AP, Keefe RS, Skelly T, Olarte M, Leviel K, Lange LA, . 2007. AKT1 and neurocognition in schizophrenia. Aust NZ J Psychiatry 41:169–177.
   PubMed Web of Science ®Google Scholar
• Salgado-Pineda P, Junque C, Vendrell P, Baeza I, Bargallo N, Falcon C, . 2004. Decreased cerebral activation during CPT performance: structural and functional deficits in schizophrenic patients. Neuroimage 21:840–847.
   PubMed Web of Science ®Google Scholar
• Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C, . 2008. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 165:497–506.
   PubMed Web of Science ®Google Scholar
• Schwab SG, Hoefgen B, Hanses C, Hassenbach MB, Albus M, Lerer B, . 2005. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry 58:446–450.
   PubMed Web of Science ®Google Scholar
• Sei Y, Li Z, Song J, Ren-Patterson R, Tunbridge EM, Iizuka Y, . 2010. Epistatic and functional interactions of catechol-o-methyltransferase (COMT) and AKT1 on neuregulin1-ErbB signaling in cell models. PLoS One 5:e10789.
   Web of Science ®Google Scholar
• Shi J, Gershon ES, Liu C. 2008. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr Res 104:96–107.
   PubMed Web of Science ®Google Scholar
• Skelley SL, Goldberg TE, Egan MF, Weinberger DR, Gold JM. 2008. Verbal and visual memory: characterizing the clinical and intermediate phenotype in schizophrenia. Schizophr Res 105:78–85.
   PubMed Web of Science ®Google Scholar
• Snitz BE, Macdonald AW, 3rd, Carter CS. 2006. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull 32:179–194.
   PubMed Web of Science ®Google Scholar
• Sugishita M. 2001. Japanese Wechsler Memory Scale-Revised. Tokyo: Nihonbunkakagakusha.
   Google Scholar
• Sui L, Wang J, Li BM. 2008. Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. Learn Mem 15:762–776.
   PubMed Web of Science ®Google Scholar
• Sun J, Kuo PH, Riley BP, Kendler KS, Zhao Z. 2008. Candidate genes for schizophrenia: a survey of association studies and gene ranking. Am J Med Genet B Neuropsychiatr Genet 147B:1173–1181.
   PubMed Web of Science ®Google Scholar
• Tan HY, Callicott JH, Weinberger DR. 2008a. Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer? Mol Psychiatry 13:233–238.
   PubMed Web of Science ®Google Scholar
• Tan HY, Nicodemus KK, Chen Q, Li Z, Brooke JK, Honea R, . 2008b. Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. J Clin Invest 118:2200–2208.
   PubMed Web of Science ®Google Scholar
• Thiselton DL, Vladimirov VI, Kuo PH, McClay J, Wormley B, Fanous A, . 2008. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol Psychiatry 63:449–457.
   PubMed Web of Science ®Google Scholar
• Tsuang M. 2000. Schizophrenia: genes and environment. Biol Psychiatry 47:210–220.
   PubMed Web of Science ®Google Scholar
• Turunen JA, Peltonen JO, Pietilainen OP, Hennah W, Loukola A, Paunio T, . 2007. The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland. Schizophr Res 91:27–36.
   PubMed Web of Science ®Google Scholar
• Wechsler D. 1987. Wechsler Memory Scale Manual, Revised. San Antonio, TX: Psychological Corporation.
   Google Scholar
• Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, . 2001a. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50:825–844.
   PubMed Web of Science ®Google Scholar
• Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, . 2001b. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50:825–844.
   PubMed Web of Science ®Google Scholar
• Xu MQ, Xing QH, Zheng YL, Li S, Gao JJ, He G, . 2007. Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population. J Clin Psychiatry 68:1358–1367.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R, . 2007. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci USA 104:20552–20557.
   PubMed Web of Science ®Google Scholar